Doncaster, Australia

Sianna Panagiotopoulos

This inventor holds 1 USPTO granted patent. Top assignees: King's College London, Peptide Technology Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sianna Panagiotopoulos. Retrieved from https://idiyas.com/inventor/sianna-panagiotopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sianna Panagiotopoulos: Innovator in Diabetes Treatment

Introduction

Sianna Panagiotopoulos is a notable inventor based in Doncaster, Australia. She has made significant contributions to the field of diabetes treatment through her innovative methods. Her work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Sianna holds a patent for a "Method for the treatment of the complications and pathology of diabetes." This patent represents her commitment to advancing medical science and providing solutions for diabetes-related issues. She has 1 patent to her name, showcasing her innovative approach to healthcare.

Career Highlights

Throughout her career, Sianna has worked with reputable organizations, including Peptide Technology Limited and King's College London. These experiences have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Sianna has had the opportunity to work alongside esteemed colleagues such as Jurgen Michaelis and Alan R Hipkiss. Their collaboration has further enriched her research and development efforts in diabetes treatment.

Conclusion

Sianna Panagiotopoulos is a pioneering inventor whose work in diabetes treatment is making a significant impact. Her dedication to innovation and collaboration highlights the importance of advancing medical solutions for chronic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…